[18F]FDG at [2] mCi - Non-Human

PETNET Pharmaceuticals Inc. has been awarded contract A207_PO-0076044-V3 by the University of Virginia on September 19, 2026. The contract is valued at $300 and involves the supply of fluorodeoxyglucose F-18 ([18F]FDG), a positron emission tomography radiopharmaceutical, in quantities of 300 units at 2 millicuries per unit. This contract represents a purchase order for non-human use delivery to the University of Virginia as the buyer.

The [18F]FDG radiopharmaceutical is a glucose analog labeled with fluorine-18 commonly utilized in positron emission tomography imaging for diagnostic purposes in research and clinical settings. The contracting organization, the University of Virginia, is based in Virginia and will serve as the place of performance and delivery location. The contract award represents a transactional procurement of radiopharmaceutical materials with a unit price of $1 per unit and a cumulative contract value of $300.